Insurance tech firm Sprout.ai secures $2.5m in additional seed funding
By Akshay Kedari  Date: 2020-04-17

Insurance tech firm Sprout.ai secures $2.5m in additional seed funding

Sprouts.ai, which is an insurtech incubated in the Imperial College of London and is applying artificial intelligence to insurance claims, has reportedly raised $2.5 million in new seed funding. Amadeus Capital Partners is leading the funding round, along with the participation of Playfair Capital as well as Techstars.

Sprout.ai was founded in 2018 and has created software that is AI-based and assures that it enables various insurance claims to be managed and settled within a time period of 24 hours. It specially uses optical character recognition and even natural language processing to clearly understand all the unstructured data related to insurance claims.

It further combines them with real-time external data like geolocation, medication information, weather, business, to either automate or escalate these for a further human analysis.

The CEO and co-founder of Sprout.ai, Niels Thone stated that the company aims to help the insurers to be able to pay out more successful claims within a span of 24 hours. The average time for claim settlement in the U.K currently has been 25 days.

Such issues are mostly caused by the dearth of information in the beginning of the claims as well as various touchpoints throughout the journey. It usually ends up with two problems, that are high operational costs and bad customer experience.

Insurance firms are capable of plugging the existing systems into the Contextual AI solution of Sprouts.ai to remedy the situation. This provides a complete data capture at the very beginning of the claims process and further validates the incoming claims while also predicting the next mandatory step of the process.

The claims bulk is then sent straight via processing which leads to them being settled in record time. Claim handlers have to primarily focus only on the complex ones which would require a specialized set of skills.

 

Source Credit- https://usa-sciencenews.com/2020/04/16/sprout-ai-raises-2-5m-to-speed-up-insurance-claims/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Rivian secures USD 2.65 billion months before its first vehicle launch
Rivian secures USD 2.65 billion months before its first vehicle launch
By Akshay Kedari

Electric vehicle startup, Rivian, backed by Ford Motor Co. and Amazon.com Inc., has reportedly announced an investment round of USD 2.65 billion led by T. Rowe Price, months before its first vehicle launch. Sources with knowledge of the matter state...

BMW drivers can now unlock and start cars without using their iPhone
BMW drivers can now unlock and start cars without using their iPhone
By Akshay Kedari

German multinational automobile manufacturer, Bayerische Motoren Werke AG, commonly known as BMW, has reportedly unveiled an upgraded version of its mobile car key technology, called the Digital Key Plus. This product enables iPhone users to unlock t...

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...